GSK plc
Top Portfolio Positions
13 positions ·
$599,153,374 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| CRSP |
CRISPR Therapeutics AG
Healthcare
|
3,220,627 | $153,205,226 | 25.57% | |
| WVE |
Wave Life Sciences Ltd.
Healthcare
|
18,245,691 | $132,281,259 | 22.08% | |
| BNTX |
BioNTech SE
Healthcare
|
889,824 | $79,087,557 | 13.20% | |
| VIR |
Vir Biotechnology, Inc.
Healthcare
|
8,550,954 | $76,616,547 | 12.79% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
1,333,333 | $44,426,655 | 7.41% | |
| LYEL |
Lyell Immunopharma, Inc.
Healthcare
|
1,512,659 | $30,343,939 | 5.06% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
340,434 | $22,438,004 | 3.74% | |
| SPRO |
Spero Therapeutics, Inc.
Healthcare
|
9,190,606 | $21,506,018 | 3.59% | |
| FULC |
Fulcrum Therapeutics, Inc.
Healthcare
|
1,785,714 | $13,696,426 | 2.29% | |
| CVRX |
CVRx, Inc.
Healthcare
|
1,007,583 | $9,531,735 | 1.59% |
Portfolio Trend
2 quarters · across all stocks
Holdings in SPRO
Shares Held
Position Value (USD)
3 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,506,018 | 9,190,606 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $21,414,111 | 9,190,606 | Shares | Sole | 2026-02-12 | |
| 2025-03-27 | $7,903,921 | 9,190,606 | Shares | Sole | 2025-03-28 | |
| No 13F history on record for this holder in this stock. | ||||||